MedPath

A Study on vadhanagandhi ennai(external medicine)in the management of mugapparu(Acne vulgaris)

Phase 3
Conditions
Health Condition 1: L700- Acne vulgaris
Registration Number
CTRI/2023/08/057058
Lead Sponsor
ational Institute of siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Clinical diagnosis of mild to moderate facial acne vulgaris with GAGS score 1-30

Patients willing and able to provide informed consent and to comply with the study protocol

Patients willing to stop using any treatment other than the investigational product for acne

Exclusion Criteria

Pregnant or lactating women

Treatment of acne vulgaris with over the counter topical medications and systemic anti acne drugs and commercially available products within 7 days prior to baseline

Use of androgen receptor blockers in the 7 days prior to randomisation

Cosmetic facial procedures within 28 days of first dose of the study

Known cases of other skin diseases

Other medications or diseases that might directly interfere in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath